TERN

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company headquartered in Foster City, California, specializing in the development of innovative small-molecule therapies for nonalcoholic steatohepatitis (NASH) and other serious chronic liver diseases. The company boasts a promising pipeline that includes both single-agent and combination therapy candidates, positioning it as a leader in addressing critical unmet medical needs in the hepatology space. Terns' dedication to advancing its clinical programs not only highlights its potential impact on patient outcomes but also demonstrates substantial value for institutional investors as it strives to bring effective therapies to market.